Effect of filgotinib on QT interval prolongation in healthy subjects
Latest Information Update: 20 Dec 2019
At a glance
- Drugs Filgotinib (Primary)
- Indications Ankylosing spondylitis; Crohn's disease; Cutaneous lupus erythematosus; Lupus nephritis; Psoriatic arthritis; Rheumatoid arthritis; Sjogren's syndrome; Ulcerative colitis; Uveitis
- Focus Pharmacodynamics
- 13 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting